{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:04:45Z","timestamp":1789452285513,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Laryngeal squamous cell carcinoma (LSCC) remains one of the most lethal malignancies of the head and neck region. Tumor metastasis, the primary cause of treatment failure, is intimately linked to the evasion of anoikis. Yet the molecular drivers of this process in LSCC are incompletely understood. This study systematically investigates the prognostic and functional landscape of anoikis-related genes (ARGs) in LSCC, with an emphasis on their interplay with the tumor immune microenvironment and therapeutic vulnerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA-sequencing profiles and clinical data from the TCGA-LSCC cohort were analyzed, and candidate anoikis-related genes (ARGs) were curated from the GeneCards and Harmonizome databases. Differentially expressed and prognosis-associated ARGs were screened using limma and univariate Cox regression. A four-gene prognostic signature was constructed in the training set using LASSO-Cox and multivariate Cox regression and internally evaluated in the testing set. The resulting anoikis-related risk score was assessed in relation to survival, clinicopathological variables, immune characteristics, pathway enrichment, and predicted drug response. Single-cell RNA-sequencing data were used to characterize the cellular distribution of the signature genes. ANXA5 was prioritized for experimental evaluation because it had the largest positive model coefficient among the risk-associated genes, showed tumor-associated dysregulation, and had biological relevance to anoikis-related processes. Its effects were examined in TU686 cells using expression, cell-viability, EMT-marker, apoptosis, and wound-healing assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ARG-based signature effectively stratified LSCC patients into high- and low-risk groups with significantly different overall survival (p &amp;lt; 0.001). High anoikis-related risk score correlated with an immunosuppressive TME, suggesting a permissive milieu for immune evasion. Drug sensitivity analysis revealed that high-risk patients were more responsive to certain tyrosine kinase inhibitors but resistant to conventional chemotherapeutics, highlighting subtype-specific therapeutic opportunities. Among the ARGs,\n                      <jats:italic>ANXA5<\/jats:italic>\n                      emerged as a hub gene with strong prognostic power.\n                      <jats:italic>In vitro<\/jats:italic>\n                      assays demonstrated that ANXA5 exerts oncogenic functions in LSCC. Following ANXA5 knockdown, we detected suppressed proliferative activity, differential expression of EMT signature genes, elevated apoptosis rate and weakened migratory ability in laryngeal squamous carcinoma cells. Collectively, these preliminary results suggest that ANXA5 is likely implicated in regulating proliferation, mesenchymal molecular traits, cell survival and migratory behaviors of laryngeal squamous carcinoma cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The four-gene anoikis-related signature showed prognostic stratification within the TCGA-LSCC cohort and was associated with differences in the tumor immune microenvironment. ANXA5 may represent a candidate prognostic biomarker and a biologically relevant gene for further mechanistic investigation; however, external validation and additional functional studies are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1941275","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:30Z","timestamp":1789450530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An anoikis-related four-gene prognostic signature and functional characterization of ANXA5 in laryngeal squamous cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Diandian","family":"Ba","sequence":"first","affiliation":[{"name":"Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.7385","article-title":"Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"36","author":"Forastiere","year":"2018","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/11769343221077118","article-title":"SPINK5 is a prognostic biomarker associated with the progression and prognosis of laryngeal squamous cell carcinoma identified by weighted gene co-expression network analysis","volume":"18","author":"Liu","year":"2022","journal-title":"Evol Bioinform Online"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01832-6","article-title":"Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma","volume":"28","author":"Xu","year":"2023","journal-title":"Apoptosis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"12913","DOI":"10.3390\/ijms241612913","article-title":"Updates on larynx cancer: risk factors and oncogenesis","volume":"24","author":"Liberale","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.21147\/j.issn.1000-9604.2020.01.03","volume-title":"Updates on larynx cancer epidemiology","author":"Nocini","year":"2020"},{"key":"B6","volume-title":"Anoikis: an emerging hallmark in health and diseases","author":"Taddei","year":"2012"},{"key":"B7","volume-title":"Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis","author":"Rennebeck","year":"2005"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"J Cell Biol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101099","volume-title":"Targeting anoikis resistance as a strategy for cancer therapy","author":"Wang","year":"2024"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B11","volume-title":"Anoikis resistance: an essential prerequisite for tumor metastasis","author":"Kim","year":"2012"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6978","volume-title":"Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma","author":"Guo","year":"2019"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1186\/s40001-025-03252-5","article-title":"Adipocytes promoted anoikis resistance of head and neck cancer cells via overexpressed ITGA5","volume":"30","author":"He","year":"2025","journal-title":"Eur J Med Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.371","article-title":"Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma","volume":"36","author":"Liao","year":"2017","journal-title":"Oncogene"},{"key":"B15","volume-title":"An anoikis-related gene prognostic model for targeted drug screening and immune landscape in head and neck squamous cell carcinoma","author":"Qiu","year":"2023"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38018","DOI":"10.1038\/s41598-025-21891-w","article-title":"CTTN overexpression in HNSCC inhibits anoikis-apoptosis","volume":"15","author":"Shen","year":"2025","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s40001-023-01521-9","article-title":"Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs","volume":"28","author":"Deng","year":"2023","journal-title":"Eur J Med Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1599171","article-title":"Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer","volume":"16","author":"Su","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109684","volume-title":"Anoikis patterns exhibit distinct prognostic and immune landscapes in osteosarcoma","author":"Zhang","year":"2023"},{"key":"B20","volume-title":"A novel anoikis-related gene prognostic signature and its association with immune infiltration in colorectal cancer","author":"Xiao","year":"2023"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1491808","article-title":"Identification of anoikis-related molecular patterns and the anoikis-related model in cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1186\/s12967-026-08470-x","article-title":"ACOT9, a mitochondrial metabolism-related gene, promotes ROS-associated epithelial remodeling in laryngeal squamous cell carcinoma","volume":"24","author":"Wang","year":"2026","journal-title":"J Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s12672-025-03074-1","article-title":"Comprehensive characterization of NK cell-related genes in cutaneous melanoma identified a novel prognostic signature for predicting the prognosis, immunotherapy, and chemotherapy efficacy","volume":"16","author":"Ma","year":"2025","journal-title":"Discov Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12672-024-01627-4","article-title":"Comprehensive characterization of neddylation related genes in cutaneous melanoma identified a novel prognostic signature for treatment outcomes, immune landscape","volume":"15","author":"Zhang","year":"2024","journal-title":"Discov Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.147098","article-title":"Lactate-related genes signature as a novel prognostic landscape in laryngeal squamous cell carcinoma: insights from 156 machine learning algorithms and in vitro validation","volume":"323","author":"Liu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"189401","DOI":"10.1016\/j.bbcan.2025.189401","article-title":"Anoikis and NETosis in colorectal cancer liver metastasis","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46001","article-title":"Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis","volume":"10","author":"Ye","year":"2020","journal-title":"Theranostics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.69933","article-title":"TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B29","volume-title":"SERPINE1 facilitates metastasis in gastric cancer","author":"Wang","year":"2025"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02873-6","article-title":"TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer","volume":"42","author":"Sun","year":"2023","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"155849","DOI":"10.1016\/j.prp.2025.155849","article-title":"Deciphering the value of anoikis-related genes in prognosis, immune microenvironment, and drug sensitivity of laryngeal squamous cell carcinoma","volume":"268","author":"Wang","year":"2025","journal-title":"Pathol Res Pract"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1941275\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:32Z","timestamp":1789450532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1941275\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1941275"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1941275","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1941275"}}